{"entity":{"type":"insider","cik":"0001557290","url":"/insider/0001557290","json_url":"/insider/0001557290.json","name":"Arbuckle Stuart A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":260,"n_filings":94,"first":"2013-07-31","last":"2024-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Arbuckle Stuart A","source":"filing","n_filings":94,"first_seen":"2013-07-31","last_seen":"2024-05-17"}],"transactions":[{"id":2106404,"accession":"0000875320-24-000152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000152","line_url":"/filing/0000875320-24-000152#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":430.93,"price_display":"430.93","price_state":"stated","total_value":29734.17,"total_display":"29,734.17","total_whole":"29,734","shares_owned_after":49691.0,"shares_owned_after_display":"49,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2620779,"accession":"0000875320-24-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000099","line_url":"/filing/0000875320-24-000099#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5034.0,"shares_display":"5,034","price_per_share":425.7,"price_display":"425.70","price_state":"stated","total_value":2142973.8,"total_display":"2,142,973.80","total_whole":"2,142,974","shares_owned_after":49691.0,"shares_owned_after_display":"49,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2337417,"accession":"0000875320-24-000087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000087","line_url":"/filing/0000875320-24-000087#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3603.0,"shares_display":"3,603","price_per_share":421.77,"price_display":"421.77","price_state":"stated","total_value":1519637.31,"total_display":"1,519,637.31","total_whole":"1,519,637","shares_owned_after":59439.0,"shares_owned_after_display":"59,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-23","scope":"insider"},{"id":3066994,"accession":"0000875320-24-000068","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-24-000068","line_url":"/filing/0000875320-24-000068#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4804.0,"shares_display":"4,804","price_per_share":420.79,"price_display":"420.79","price_state":"stated","total_value":2021475.16,"total_display":"2,021,475.16","total_whole":"2,021,475","shares_owned_after":63042.0,"shares_owned_after_display":"63,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":2058803,"accession":"0000875320-24-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000043","line_url":"/filing/0000875320-24-000043#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4295.0,"shares_display":"4,295","price_per_share":420.24,"price_display":"420.24","price_state":"stated","total_value":1804930.8,"total_display":"1,804,930.80","total_whole":"1,804,931","shares_owned_after":75718.0,"shares_owned_after_display":"75,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":8505659,"accession":"0000875320-23-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-23-000056","line_url":"/filing/0000875320-23-000056#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8603.0,"shares_display":"8,603","price_per_share":399.0,"price_display":"399.00","price_state":"stated","total_value":3432597.0,"total_display":"3,432,597.00","total_whole":"3,432,597","shares_owned_after":56556.0,"shares_owned_after_display":"56,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":8500566,"accession":"0001209191-23-038343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-038343","line_url":"/filing/0001209191-23-038343#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8603.0,"shares_display":"8,603","price_per_share":349.0,"price_display":"349.00","price_state":"stated","total_value":3002447.0,"total_display":"3,002,447.00","total_whole":"3,002,447","shares_owned_after":56556.0,"shares_owned_after_display":"56,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":7998319,"accession":"0001209191-23-033321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033321","line_url":"/filing/0001209191-23-033321#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":329.82,"price_display":"329.82","price_state":"stated","total_value":27045.24,"total_display":"27,045.24","total_whole":"27,045","shares_owned_after":56556.0,"shares_owned_after_display":"56,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider"},{"id":8722913,"accession":"0001209191-23-013708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-013708","line_url":"/filing/0001209191-23-013708","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5034.0,"shares_display":"5,034","price_per_share":287.4738657131506,"price_display":"287.47","price_state":"stated","total_value":1447143.44,"total_display":"1,447,143.44","total_whole":"1,447,143","shares_owned_after":57756.0,"shares_owned_after_display":"57,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider","n_lines":3},{"id":7867930,"accession":"0001209191-23-012672","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-012672","line_url":"/filing/0001209191-23-012672","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2401.0,"shares_display":"2,401","price_per_share":294.3268221574344,"price_display":"294.33","price_state":"stated","total_value":706678.7,"total_display":"706,678.70","total_whole":"706,679","shares_owned_after":66898.0,"shares_owned_after_display":"66,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-24","scope":"insider","n_lines":5},{"id":7917270,"accession":"0001209191-23-011665","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-011665","line_url":"/filing/0001209191-23-011665","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2402.0,"shares_display":"2,402","price_per_share":293.7534304746045,"price_display":"293.75","price_state":"stated","total_value":705595.74,"total_display":"705,595.74","total_whole":"705,596","shares_owned_after":69441.0,"shares_owned_after_display":"69,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider","n_lines":4},{"id":7917101,"accession":"0001209191-23-010050","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-010050","line_url":"/filing/0001209191-23-010050","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6398.0,"shares_display":"6,398","price_per_share":298.68110346983434,"price_display":"298.68","price_state":"stated","total_value":1910961.7,"total_display":"1,910,961.70","total_whole":"1,910,962","shares_owned_after":77739.0,"shares_owned_after_display":"77,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider","n_lines":6},{"id":8627526,"accession":"0001209191-23-009182","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-009182","line_url":"/filing/0001209191-23-009182","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4887.0,"shares_display":"4,887","price_per_share":298.91869244935543,"price_display":"298.92","price_state":"stated","total_value":1460815.65,"total_display":"1,460,815.65","total_whole":"1,460,816","shares_owned_after":84617.0,"shares_owned_after_display":"84,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider","n_lines":4},{"id":6741720,"accession":"0000899243-22-029030","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-029030","line_url":"/filing/0000899243-22-029030","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22173.0,"shares_display":"22,173","price_per_share":303.9277851440942,"price_display":"303.93","price_state":"stated","total_value":6738990.78,"total_display":"6,738,990.78","total_whole":"6,738,991","shares_owned_after":52226.0,"shares_owned_after_display":"52,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider","n_lines":6},{"id":6914810,"accession":"0000899243-22-028474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-028474","line_url":"/filing/0000899243-22-028474","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":300.4045,"price_display":"300.40","price_state":"stated","total_value":54072.81,"total_display":"54,072.81","total_whole":"54,073","shares_owned_after":60889.0,"shares_owned_after_display":"60,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider","n_lines":2},{"id":6291217,"accession":"0000899243-22-028244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-028244","line_url":"/filing/0000899243-22-028244","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5690.0,"shares_display":"5,690","price_per_share":300.67077328646747,"price_display":"300.67","price_state":"stated","total_value":1710816.7,"total_display":"1,710,816.70","total_whole":"1,710,817","shares_owned_after":61896.0,"shares_owned_after_display":"61,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider","n_lines":2},{"id":6741269,"accession":"0000899243-22-018610","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-018610","line_url":"/filing/0000899243-22-018610","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":251.19,"price_display":"251.19","price_state":"stated","total_value":33408.27,"total_display":"33,408.27","total_whole":"33,408","shares_owned_after":64760.0,"shares_owned_after_display":"64,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider","n_lines":7},{"id":6840855,"accession":"0000899243-22-016653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016653","line_url":"/filing/0000899243-22-016653#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":306.0,"shares_display":"306","price_per_share":263.98,"price_display":"263.98","price_state":"stated","total_value":80777.88,"total_display":"80,777.88","total_whole":"80,778","shares_owned_after":64760.0,"shares_owned_after_display":"64,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":4188776,"accession":"0001209191-21-064738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064738","line_url":"/filing/0001209191-21-064738","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001557290","owner_name":"Arbuckle Stuart A","owner_display_name":"Arbuckle Stuart A","owner_url":"/insider/0001557290","role":"Officer (EVP, COO)","role_mark":"O","role_mark_label":"Officer (EVP, COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":187.26,"price_display":"187.26","price_state":"stated","total_value":561.78,"total_display":"561.78","total_whole":"562","shares_owned_after":41104.0,"shares_owned_after_display":"41,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-11-15|4188772","ledger_fault":false,"count":{"value":260,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":260,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":260},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, COO)","n_filings":94,"first_seen":"2013-07-31","last_seen":"2024-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557290","retrieved_at":"2026-08-24T19:09:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}